CN109966422A - A kind of desert cistanche lily blood-sugar reducing tea and preparation method thereof - Google Patents

A kind of desert cistanche lily blood-sugar reducing tea and preparation method thereof Download PDF

Info

Publication number
CN109966422A
CN109966422A CN201910231868.5A CN201910231868A CN109966422A CN 109966422 A CN109966422 A CN 109966422A CN 201910231868 A CN201910231868 A CN 201910231868A CN 109966422 A CN109966422 A CN 109966422A
Authority
CN
China
Prior art keywords
blood
parts
lily
sugar reducing
reducing tea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910231868.5A
Other languages
Chinese (zh)
Inventor
朱晓华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Weiyuan Huiyuan Pharmaceutical Co Ltd
Original Assignee
Weiyuan Huiyuan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Weiyuan Huiyuan Pharmaceutical Co Ltd filed Critical Weiyuan Huiyuan Pharmaceutical Co Ltd
Priority to CN201910231868.5A priority Critical patent/CN109966422A/en
Publication of CN109966422A publication Critical patent/CN109966422A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966—Fritillaria, e.g. checker lily or mission bells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967—Lilium, e.g. tiger lily or Easter lily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968—Ophiopogon (Lilyturf)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of desert cistanche lily blood-sugar reducing teas and preparation method thereof, it is characterized in that, the blood-sugar reducing tea is grouped as by the group of following parts by weight: Herba Cistanches group expects 6~10 parts, 3~8 parts of hawthorn, 1~5 part of lily, 1~5 part of fructus lycii, 2~6 parts of Radix Ophiopogonis, 0.5~1.5 part of reed root, 0.1~0.8 part of Chinese tamarisk tops, 1~5 part of fritillaria, the blood-sugar reducing tea hypoglycemic effect being prepared is good and Small side effects, human physiological functions are adjusted in long-term drinking, improve body immunity, enhancing metabolism, restore islet function, it is suitble to numerous diabetics to use, and the problem of blurring of image caused by diabetes can be effectively relieved.

Description

A kind of desert cistanche lily blood-sugar reducing tea and preparation method thereof
Technical field
The present invention relates to tea-drinking technical fields, and in particular to a kind of desert cistanche lily blood-sugar reducing tea and preparation method thereof.
Background technique
Diabetes be it is a kind of due to caused by defect of insulin secretion or insulin action obstacle characterized by hyperglycemia Metabolic disease.Persistent high blood sugar and long-term metabolic disorder etc. can lead to body tissue's organ, especially eye, kidney, angiocarpy and The damage of nervous system and its dysfunction and failure.Serious person can cause dehydration, electrolyte disturbance and acid-base imbalance etc. Acute complications ketoacidosis and Hyperosmotic coma.
Blood-sugar reducing tea, which has, to be promoted human body glycometabolism and is allowed to balance, to reach hypoglycemic, protects simultaneously repairing islet cells, Complication is reversed, blood-sugar content is allowed gradually to tend to be normal.Such as the patent of invention of Publication No. CN106982958A discloses one Kind blood-sugar reducing tea and preparation method thereof, the blood-sugar reducing tea is by 5 kinds of daye tea, pueraria lobata, Guava Leaf, barley young leaf and aloe raw materials It is made, the preparation method comprises the following steps: daye tea, pueraria lobata and Guava Leaf are mixed, pulverizes；Barley seedling segment and aloe is thin Piece is freeze-dried to moisture content lower than 5wt%；By after freeze-drying barley seedling segment and aloe thin slice at 5 DEG C or less Low temperature environment under carry out air-flow crushing；Bag distribution packaging.
Another technical solution set forth below.
Summary of the invention
In view of the deficiencies of the prior art, the object of the present invention is to provide a kind of Small side effects, price is low, hypoglycemic effect is good A kind of desert cistanche lily blood-sugar reducing tea and preparation method thereof.
The present invention is realized by following implementation:
A kind of desert cistanche lily blood-sugar reducing tea, the blood-sugar reducing tea are grouped as by the group of following parts by weight: Herba Cistanches group material 6~10 Part, 3~8 parts of hawthorn, 1~5 part of lily, 1~5 part of fructus lycii, 2~6 parts of Radix Ophiopogonis, 0.5~1.5 part of reed root, Chinese tamarisk tops 0.1~0.8 Part, 1~5 part of fritillaria.
Preferably, the reed root: the weight part ratio of Chinese tamarisk tops is 2: 1.
Preferably, the water content of the Radix Ophiopogonis is 20%~25%.
Preferably, the blood-sugar reducing tea is grouped as by the group of following parts by weight: Herba Cistanches group expects 7 parts, 5 parts of hawthorn, lily 3 Part, 3 parts of fructus lycii, 4 parts of Radix Ophiopogonis, 1 part of reed root, 0.5 part of Chinese tamarisk tops, 3 parts of fritillaria.
It preferably, further include 2~3 parts of Schisandra chinensis, 4~7 parts of mulberry leaf of freeze-drying in terms of the component of parts by weight.
Preferably, the Herba Cistanches group material is the anti-oxidant combination of blueberry, cistanche extracts, rhizoma polygonati and fleece-flower root compatibility Object.
Invention additionally discloses a kind of preparation methods of desert cistanche lily blood-sugar reducing tea, realize especially by following implementation:
A kind of preparation method of desert cistanche lily blood-sugar reducing tea, comprising the following steps:
(1) it weighs: weighing Herba Cistanches group by the weight of the blood-sugar reducing tea each component and expect, hawthorn, lily, fructus lycii, Radix Ophiopogonis, reed root, Chinese tamarisk tops, fritillaria；
(2) preparation freeze-drying mulberry leaf: cleaning new fresh mulberry leaf piece and sterilize, the new fresh mulberry leaf piece sterilized, by disinfection New fresh mulberry leaf piece, which is put into refrigerator, to be freeze-dried to get the freeze-drying mulberry leaf；
(3) it is mixed: weighing the freeze-drying being prepared in step (2) by the weight of the blood-sugar reducing tea each component Freeze-drying mulberry leaf, Herba Cistanches group are expected, hawthorn, lily, fructus lycii, Radix Ophiopogonis, reed root, Chinese tamarisk tops, fritillaria is put into blender and stirs by mulberry leaf It mixes uniformly, obtains mixture；
(4) it packs: by the packed tea bag that is made of the mixture to get the blood-sugar reducing tea.
Preferably, peeling processing is carried out to fresh meat desert cistanche, is dried at 40-60 DEG C obtained of Herba Cistanches skin, after dry Herba Cistanches skin crushed, powder crosses 80 meshes, and 1-2 times of powder weight of 90% ethyl alcohol is added toward powder, continues to do When the weight ratio of dry waiting powder and ethyl alcohol is 2: 1, cistanche extracts, rhizoma polygonati and the stirring of fleece-flower root compatibility is added, then exists Compacting then continues to crush in bulk on hot press.
In conclusion compared with prior art, the invention has the advantages that,
Herba Cistanches are a kind of parasitic plants for colonizing in desert trees sacsaoul root, and nutrient and water are drawn from sacsaoul host Point.It is known as the good reputation of " desert ginseng ", there is high medical value, be the rare traditional Chinese medicine of Chinese tradition.Herba Cistanches are being gone through Just by Western Regions various countries as the highest help of usage frequency in the treasure and successive dynasties tonifying kidney and strengthening yang class prescription of Shang Gong imperial court in history One of drug.
Hawthorn contains a variety of organic acids.Enhance gastric acidity after oral, improves pepsin activity, promote disappearing for protein Change；Hawthorn is sour, and stimulation stomach lining promotes gastric secretion；Fatty enzyme in hawthorn can promote the digestion of fat；Hawthorn contains dimension The ingredients such as raw element C, it is oral to improve a poor appetite；Hawthorn has adjustment effect to gastrointestinal motility function, flat to the stomach and intestine of spasticity Sliding flesh has inhibiting effect, has excitation to the smooth muscle of relaxed state.
It is inhibited to respiratory system；With liver protection effect；Inhibit bacterial growth, still has the effects that antipyretic.Water Decoction carries out pharmacological testing, the results show that having apparent cough-suppressing phlegm-dispelling functions, to streptococcus pneumonia, alpha streptococcus, white Portugal Grape coccus and Bacillus influenzae have inhibiting effect.
A kind of preparation method of desert cistanche lily blood-sugar reducing tea of the present invention, the blood-sugar reducing tea hypoglycemic effect being prepared is good and side effect Small, human physiological functions are adjusted in long-term drinking, improve body immunity, and enhancing metabolism restores islet function, are suitble to wide Big diabetic uses, and the various raw material sources for preparing the blood-sugar reducing tea are wide, and preparation method is simple, and production cost is low.
The suitable freeze-drying mulberry leaf of proportion and corn stigma is added in a kind of preparation method of desert cistanche lily blood-sugar reducing tea of the present invention, The problem of being lyophilized under the synergistic effect of mulberry leaf and corn stigma, the blurring of image caused by diabetes can be effectively relieved, accelerates simultaneously Rate of patients' visual recovery.
A kind of preparation method of desert cistanche lily blood-sugar reducing tea of the present invention, is added suitable Schisandra chinensis, can play alleviation glycosuria The weary effect of the tired body of patient's body.
New fresh mulberry leaf piece, is first put by a kind of preparation method of desert cistanche lily blood-sugar reducing tea of the present invention when mulberry leaf are lyophilized in preparation It is impregnated in sodium alginate soln, then new fresh mulberry leaf piece is put into refrigerator and is freeze-dried, the careless raw meat of freeze-drying mulberry leaf can be eliminated Taste plays the role of improving blood-sugar reducing tea mouthfeel.
Specific embodiment
The following examples can help those skilled in the art that the present invention is more fully understood, but cannot be with any Mode limits the present invention.
Embodiment 1, a kind of desert cistanche lily blood-sugar reducing tea, the blood-sugar reducing tea are grouped as by the group of following parts by weight: Herba Cistanches Group expects 6 parts, 3 parts of hawthorn, 1 part of lily, 1 part of fructus lycii, 2 parts of Radix Ophiopogonis, 0.5 part of reed root, 0.25 part of Chinese tamarisk tops, 1 part of fritillaria, wherein reed Root: the weight part ratio of Chinese tamarisk tops is 2: 1.
Embodiment 2, a kind of desert cistanche lily blood-sugar reducing tea, difference from example 1 is that, the blood-sugar reducing tea is by following The group of parts by weight is grouped as: Herba Cistanches group expects 6 parts, 3 parts of hawthorn, 1 part of lily, 1 part of fructus lycii, 2 parts of Radix Ophiopogonis, 0.75 part of reed root, west 0.25 part of dryland willow, 1 part of fritillaria, wherein reed root: the weight part ratio of Chinese tamarisk tops is 3: 1.
Embodiment 3, a kind of desert cistanche lily blood-sugar reducing tea, difference from example 1 is that, the blood-sugar reducing tea is by following The group of parts by weight is grouped as: Herba Cistanches group expects 10 parts, 8 parts of hawthorn, 5 parts of lily, 5 parts of fructus lycii, 6 parts of Radix Ophiopogonis, 1.5 parts of reed root, west 0.8 part of dryland willow, 5 parts of fritillaria.
Embodiment 4, a kind of desert cistanche lily blood-sugar reducing tea, difference from example 1 is that, the blood-sugar reducing tea is by following The group of parts by weight is grouped as: Herba Cistanches group expects 7 parts, 5 parts of hawthorn, 3 parts of lily, 3 parts of fructus lycii, 4 parts of Radix Ophiopogonis, 1 part of reed root, Chinese tamarisk tops 0.5 part, 3 parts of fritillaria.
Embodiment 5, a kind of desert cistanche lily blood-sugar reducing tea, the difference is that, the water content of the Radix Ophiopogonis is with embodiment 4 20%~25%.
Embodiment 6, a kind of desert cistanche lily blood-sugar reducing tea the difference is that, further include Schisandra chinensis 2~3 with embodiment 4 Part, 4~7 parts of mulberry leaf of freeze-drying.The material of Herba Cistanches group described in above-mentioned component is that blueberry, cistanche extracts, rhizoma polygonati and the fleece-flower root are matched 5 antioxidant composition.
Embodiment 7, a kind of preparation method of desert cistanche lily blood-sugar reducing tea, are once prepared step using the component of embodiment 6 It is rapid:
(1) it weighs: weighing Herba Cistanches group by the weight of the blood-sugar reducing tea each component and expect, hawthorn, lily, fructus lycii, Radix Ophiopogonis, reed root, Chinese tamarisk tops, fritillaria；
(2) preparation freeze-drying mulberry leaf: cleaning new fresh mulberry leaf piece and sterilize, the new fresh mulberry leaf piece sterilized, by disinfection New fresh mulberry leaf piece, which is put into refrigerator, to be freeze-dried to get the freeze-drying mulberry leaf；
(3) it is mixed: weighing the freeze-drying being prepared in step (2) by the weight of the blood-sugar reducing tea each component Freeze-drying mulberry leaf, Herba Cistanches group are expected, hawthorn, lily, fructus lycii, Radix Ophiopogonis, reed root, Chinese tamarisk tops, fritillaria is put into blender and stirs by mulberry leaf It mixes uniformly, obtains mixture；
(4) it packs: by the packed tea bag that is made of the mixture to get the blood-sugar reducing tea.
Embodiment 8, a kind of preparation method of desert cistanche lily blood-sugar reducing tea, with embodiment 7 the difference is that, to fresh meat desert Rong carries out peeling processing, is dried at 40-60 DEG C obtained of Herba Cistanches skin, and the Herba Cistanches skin after drying is crushed, powder 80 meshes are crossed, 1-2 times of powder weight of 90% ethyl alcohol is added toward powder, continue the dry weight ratio for waiting powder and ethyl alcohol When being 2: 1, cistanche extracts, rhizoma polygonati and the stirring of fleece-flower root compatibility is added, then compacting is in bulk on hot press, and subsequent Continued powder is broken.
Experimental data
Inventor finds diabetic 20, and big 60 years old, small 40 years old, diabetic history was most 1 year short, and longest 8 years, According to close situation, divides three groups and is tested:
From 18 patients with diabetes mellitus situations of test, everybody generally reflects, this blood-sugar reducing tea has apparent hypoglycemic to imitate Fruit.
Typical case:
1, Zhang, male, 60 years old, Dingxi City Tongwei County.There is II diabetic history 5 years, usually uses a kind of antidiabetic drug, fasting blood-glucose Index control is in 6.5mmol/L or so, and after drink blood-sugar reducing tea 2 weeks, fasting blood-glucose is controlled in 4mmol/L or less.
2, Lee, female, 40 years old, there was type-2 diabetes mellitus history in Dingxi City Anding District 1 year, usually used a kind of antidiabetic drug, fasting blood Sugared index 7.5mmol/L or so, after being drunk blood-sugar reducing tea 5 days, fasting blood-glucose control just drinks hypoglycemic even without medicine in 4mmol/L Tea can be also controlled fasting blood-glucose in 5mmol/L.
3, week certain, male, 45 years old, Dingxi City Zhang County, diabetic history 5 years, usually use a kind of antidiabetic drug, fasting blood-glucose control exists 7mmol/L just drinks blood-sugar reducing tea even without medicine in 4mmol/L hereinafter, fasting blood-glucose is controlled, and fasting blood-glucose can also be controlled and be existed 5.5mmol/L。

Claims (8)

1. a kind of desert cistanche lily blood-sugar reducing tea, which is characterized in that the blood-sugar reducing tea is grouped as by the group of following parts by weight:
Herba Cistanches group expect 6~10 parts, 3~8 parts of hawthorn, 1~5 part of lily, 1~5 part of fructus lycii, 2~6 parts of Radix Ophiopogonis, reed root 0.5~ 1.5 parts, 0.1~0.8 part of Chinese tamarisk tops, 1~5 part of fritillaria.
2. a kind of desert cistanche lily blood-sugar reducing tea according to claim 1, which is characterized in that the reed root: the weight of Chinese tamarisk tops Part is than being 2: 1.
3. a kind of desert cistanche lily blood-sugar reducing tea according to claim 1, which is characterized in that the water content of the Radix Ophiopogonis is 20% ~25%.
4. a kind of desert cistanche lily blood-sugar reducing tea according to claim 1, which is characterized in that the blood-sugar reducing tea is by following weight The group of part is grouped as: Herba Cistanches group expects 7 parts, 5 parts of hawthorn, 3 parts of lily, 3 parts of fructus lycii, 4 parts of Radix Ophiopogonis, 1 part of reed root, Chinese tamarisk tops 0.5 Part, 3 parts of fritillaria.
5. a kind of desert cistanche lily blood-sugar reducing tea according to claim 1, which is characterized in that in terms of the component of parts by weight, also wrap Include 2~3 parts of Schisandra chinensis, 4~7 parts of mulberry leaf of freeze-drying.
6. a kind of desert cistanche lily blood-sugar reducing tea according to claim 1, which is characterized in that Herba Cistanches group material be blueberry, The antioxidant composition of cistanche extracts, rhizoma polygonati and fleece-flower root compatibility.
7. a kind of preparation method of desert cistanche lily blood-sugar reducing tea described in any one of claim 1-4, which is characterized in that including Following steps:
(1) it weighs: weighing Herba Cistanches group by the weight of the blood-sugar reducing tea each component and expect, hawthorn, lily, fructus lycii, Radix Ophiopogonis, Reed root, Chinese tamarisk tops, fritillaria；
(2) preparation freeze-drying mulberry leaf: cleaning new fresh mulberry leaf piece and sterilize, the new fresh mulberry leaf piece sterilized, by the fresh of disinfection Mulberry leaf piece is put into refrigerator and is freeze-dried to get the freeze-drying mulberry leaf；
(3) it is mixed: weighing the freeze-drying mulberry being prepared in step (2) by the weight of the blood-sugar reducing tea each component Freeze-drying mulberry leaf, Herba Cistanches group are expected, hawthorn, lily, fructus lycii, Radix Ophiopogonis, reed root, Chinese tamarisk tops, fritillaria is put into blender and stirs by leaf Uniformly, mixture is obtained；
(4) it packs: by the packed tea bag that is made of the mixture to get the blood-sugar reducing tea.
8. a kind of preparation method of desert cistanche lily blood-sugar reducing tea according to claim 5, which is characterized in that fresh meat desert cistanche into Row peeling is handled, and is dried at 40-60 DEG C obtained of Herba Cistanches skin, and the Herba Cistanches skin after drying is crushed, and powder crosses 80 1-2 times of powder weight of 90% ethyl alcohol is added toward powder for mesh, and the weight ratio for continuing dry waiting powder and ethyl alcohol is 2: When 1, cistanche extracts, rhizoma polygonati and the stirring of fleece-flower root compatibility is added, then compacting is in bulk on hot press, then after continued powder It is broken.
CN201910231868.5A 2019-03-26 2019-03-26 A kind of desert cistanche lily blood-sugar reducing tea and preparation method thereof Pending CN109966422A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910231868.5A CN109966422A (en) 2019-03-26 2019-03-26 A kind of desert cistanche lily blood-sugar reducing tea and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910231868.5A CN109966422A (en) 2019-03-26 2019-03-26 A kind of desert cistanche lily blood-sugar reducing tea and preparation method thereof

Publications (1)

Publication Number Publication Date
CN109966422A true CN109966422A (en) 2019-07-05

Family

ID=67080602

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910231868.5A Pending CN109966422A (en) 2019-03-26 2019-03-26 A kind of desert cistanche lily blood-sugar reducing tea and preparation method thereof

Country Status (1)

Country Link
CN (1) CN109966422A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106942561A (en) * 2017-05-02 2017-07-14 陈霞 A kind of beverage composition for treating dental erosion and preparation method and application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106942561A (en) * 2017-05-02 2017-07-14 陈霞 A kind of beverage composition for treating dental erosion and preparation method and application

Similar Documents

Publication Publication Date Title
CN102919836B (en) Health-care product capable of reducing blood glucose, releasing pressure, reducing lipid, relaxing bowel, beautifying, losing weight and resisting fatigue and production process thereof
CN102907604B (en) Health-care product having effects of reducing blood sugar and pressure, losing weight, relaxing bowels, maintaining beauty and resisting fatigue and production process thereof
CN103141684B (en) Composite rabbit feed containing Chinese medicinal herbs
CN103598490B (en) Tortoise jelly for invigorating spleen and tonifying kidneys, and preparation technology thereof
CN112425767A (en) Beauty-maintaining and young-keeping probiotic fermentation powder and production method thereof
CN113332354B (en) Anti-saccharification anti-aging fermented composition and preparation method thereof
CN110051815A (en) A kind of auxiliary hyperglycemic food ball and preparation method thereof
CN101347188A (en) Feed for laying hen and method for processing egg using tinctura made from Chinese medicine
CN103405657B (en) Medicine for treating cough and preparation method thereof
CN109170863A (en) A kind of functional sugar ferment and preparation method thereof
CN105326910A (en) Health-preserving liquor and preparing method thereof
CN117137131A (en) Polygonatum sibiricum and wolfberry enzyme powder and preparation method thereof
CN105395674B (en) A kind of Traditional Chinese medicine probiotic compound formulation and preparation method thereof for preventing and treating fowl gland ventriculitis
CN103920140B (en) A kind of people is with blood sugar lowering Weight-reducing and lipid-lowering compound preparation
CN107136513A (en) Adjust the health food of colony balance, preparation method and applications in human body
CN106036849A (en) Healthcare green plum food and preparation method thereof
KR101935848B1 (en) Food composition for improving hyperglycemia using Brassica rapa
CN1426810A (en) Anti alcoholic agent using alder as material and mfg. method thereof
CN109966422A (en) A kind of desert cistanche lily blood-sugar reducing tea and preparation method thereof
CN104673572A (en) Anti-aging wine with functions of beautifying and keeping youthfulness and method for preparing anti-aging wine with functions of beautifying and keeping youthfulness
CN104222293A (en) Chewable Qi tonifying yoghourt tablet and production method thereof
CN104799014A (en) Natural plant feed additive for promoting healthy development of digestive tract of weaned piglet and preparing method thereof
CN109430668A (en) A kind of Portable solid diet drink and its preparation and concocting method
CN109007509A (en) A kind of lily tea solid beverage and preparation method thereof
CN107094930A (en) A kind of tea for improving sleep quality and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190705

WD01 Invention patent application deemed withdrawn after publication